Aids Lymphoma, Hyperthermia Holistic Center

Home Up Table of Contents Search Links Info  Request News

Valley Cancer Institute    Hyperthermia, the most effective-low or non side effects cancer treatment available now days!

inforequest@vci.org / (310)398-0013 / Los Angeles, California, USA

 

 

Ask the Doctor!!!
any question about
clinical use of
Hyperthermia
"Chat" with the Doctor!

- Latest Results
  Breast Cancer,
  Prostate Cancer,
  Head and Neck
  Cancer Treatm.

- Benefits and
  Features of
  Hyperthermia

- Patients
  Testimonies.
  Interviews with
  Patients

- Video Testimonies

Pictures and information on cancer treatment on different areas treated with Hyperthermia and low radiation dose

 ADENOCARCINOMA
 CANCER TREATMENT   

AIDS LYMPHOMA CANCER  

 
BRAIN CANCER TUMOR   

 
BREAST CANCER

 
SINUS SARCOMA CANCER


 
INFLAMMATORY BREAST
 CANCER (IBC) TUMOR


 
PROSTATE CANCER TUMOR

 
TONSIL CANCER TUMOR

 
NECK CANCER TUMOR I

 
NECK CANCER TUMOR II

 
BREAST CANCER, HEAD
   and NECK TUMOR, DEEP
   TUMORS

_______________________

 

- Hyperthermia
  Resources

- Accommodations

- Effectiveness of Daily
  Hyperthermia

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   (310)398-0013

inforequest@vci.org

ADENOCARCINOMA CANCER / AIDS LYMPHOMA CANCER / BRAIN CANCER TUMOR / BREAST CANCER / SINUS SARCOMA CANCER
  INFLAMMATORY BREAST CANCER IBC TUMOR / PROSTATE CANCER TUMOR / TONSIL CANCER TUMOR / NECK CANCER TUMOR I
NECK CANCER TUMOR II / BREAST CANCER, HEAD and NECK TUMOR, DEEP TUMORS

    One patient results. Aids Induced Lymphoma.
    These pictures were taken before and after one Aids Induced Lymphoma Hyperhermia treatment, combined with low dose of Radiation.

    Thermoradiotherapy (Hyperthermia combined with low dose radiation) Hyperfractionation technique (division or fractionation of radiation therapy in small radiation doses) was used to treat this case of Aids Induced Lymphoma.  

    Before treatment, Friday, 03/13/98.                 After one treatment, Monday, 03/16/98.

Aids Induced Lymphoma, Cancer of the Neck, Picture before treatment Aids Induced Lymphoma, Cancer of the Neck, - Picture after treatment

You are visitor No.: Hit Counter

WB01337_.gif (904 bytes)          WB01339_.gif (896 bytes)          Top of Page / Home / Back / This Patient Treatment Set Up /Treatment Results

THERMORADIOTHERAPY FRACTIONATION IN THE CLINICAL

TREATMENT OF MALIGNANT TUMORS

Bicher, H., M. D.

Valley Cancer Institute, Los Angeles, CA, U.S.A

Hyperthermia has been proven to increase the response of malignant tumors to radiation therapy in both experimental animal tumors and the clinical treatment of human cancer. Based on our multi-year experience, first in re-treatment of previously radiated fields that necessitated the use of low dose radiation fractions as adjunct to the heat treatments, and then progressively applying the encouraging results obtained to areas treated "de novo" and eventually to situations allowing a potentially curative intent, treatment protocols have been devised and tested that yield positive preliminary data showing superior tumor response rates and less side effects when compared with historical controls at our Institute.

The hyperthermia part of the protocol extends the number of heat treatments to correspond to the number of radiation-fractions, as each hyperthermia treatment proceeds or follows each radiation treatment in close time proximity. The number of hyperthermia treatments therefore varies from 25-50 per course for each treated field.

The radiation protocol consists of progressively decreasing daily doses of radiation therapy combined with the daily hyperthermia treatments. Typically the treatment is started at a daily dose of 180cGy gradually reduced to 100cGy protracting a typical radiation therapy treatment course from 5000cGy in five weeks to 5000cGy given in over eight weeks; or 7000cGy in seven weeks to 7000cGy in 14 weeks. According to the ELLIS TDF formula, this results in a 15% or 25% reduction of the effective radiation dose. The total dose is of course adapted to the clinical situation.

The following Conclusions are drawn:

CONCLUSIONS

Protracted Hyperfractionation

    1. Decreases the radiation dose by 15% and 24%.
    2. Decreases the side effects of XRT (no diarrhea, fistula or pneumonitis in PH cases)
    3. Allows for more combined XRT-Hyperthermia treatments
    4. Increases the effectiveness of the combined treatment in superficial and deep tumors.

   Top of Page / Home / Back / This Patient Treatment Set Up /Treatment Results

Home ] Up ][Links]

______________________________________________________________________________________________________________________________________________________________________________
Call for more information:  (310)398-0013, and ask for Nash. Thanks

General Information: inforequest@vci.org

12099 W. Washington Blvd.,#304
Los Angeles, CA 90066

Last modified: June 29, 2009